SCHEMBL5260129

SCHEMBL5260129

CCCCNS(=O)(=O)N(CC(=O)O)Cc1ccc(OCCc2nc(-c3ccc(C)cc3)oc2C)cc1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.60
PPARA Q07869 19/20 0.60
PPARD Q03181 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5230633 0.87 PPARA (0.62) PPARGPPARA
SCHEMBL5226678 0.85 PPARG (0.63) PPARGPPARAPPARD
SCHEMBL5226605 0.84 PPARA (0.64) PPARGPPARA
SCHEMBL5228792 0.82 PPARG (0.62) PPARGPPARA
SCHEMBL5265858 0.81 PPARA (0.64) PPARGPPARA
SCHEMBL5428709 0.80 PPARA (0.55) PPARGPPARAPPARD
SCHEMBL14361124 0.79 PPARA (0.61) PPARGPPARA
SCHEMBL5227428 0.79 PPARG (0.75) PPARGPPARA
SCHEMBL5227226 0.79 PPARA (0.66) PPARGPPARA
SCHEMBL5223157 0.79 PPARG (0.69) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778654-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME Crystalgenomics, Inc. (KR) 2007-05-02 EP claimed
WO-2006006832-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME CRYSTALGENOMICS, INC. (KR) 2006-01-19 WO claimed